Abbott told CHI Health that its supply of testing reagents will be limited for the next four to five weeks.
CHI Health was one of the only health systems in the area requiring a COVID-19 test before an elective surgery, KSNB reported.
CHI Health said suspending pre-surgical COVID-19 testing won’t affect its elective surgeries.
“Surgeons and staff will continue to wear proper N95 masks and other essential PPE at all times to protect our medical teams and our patients. CHI Health does not have a PPE shortage and the safety of our patients and staff remains our highest priority. By suspending pre-procedural tests, we are able to preserve tests for people experiencing symptoms in the communities we serve,” a CHI Health spokesperson told KSNB.
Read the full article here.
More articles on supply chain:
Bon Secours looking to hire a CFO of supply chain
How NYC Health + Hospitals’ ingenuity resolved supply chain challenges at pandemic’s height
Michigan has enough PPE for 2nd coronavirus wave, local hospital association says
